期刊文献+

974例胃癌患者预后因素分析 被引量:3

An Analysis of Prognostic Factors in 974 Patients with Gastric Cancer
下载PDF
导出
摘要 目的:回顾性分析974例胃癌患者的资料,探讨影响胃癌生存的预后因素。方法:采用回顾性调查研究方法,分析974例胃癌患者病历资料。采用Kaplan-Meier方法进行生存率分析,Log-rank检验进行单因素分析,COX比例风险模型分析胃癌预后的相关因素。结果:患者的性别、发病年龄、吸烟史、饮酒史、肿瘤家族史、肿瘤类型、是否化疗等7个因素与胃癌预后无明显相关性;胃癌肿瘤侵袭范围、病理类型、组织分化程度、是否转移、临床TNM分期、手术方式和是否接受中药治疗等7个因素是其预后的独立影响因素(P<0.05),其中肿瘤局部浸润范围、肿瘤病理分型、组织分化程度、伴有转移、临床TNM分期是患者的危险因素,而接受根治性手术和中医药治疗是胃癌预后的保护性因素。结论:肿瘤局部浸润范围广、肿瘤组织学分型复杂、组织分化差、伴有转移、临床分期晚的胃癌患者预后较差;接受根治性手术和选择中医药治疗可改善其预后。 Objective: To explore the prognostic factors that influenced the survival of gastric cancer through the retrospective analysis of 974 patients with gastric cancer. Methods: In this study, a total of 974 cases of gastric cancer patients were collected. This study used retrospective study method, Kaplan-Meier method for sur- vival rate analysis, Log-rank test for single factor analysis, COX's proportional hazards regression model for prognostic factors analysis of gastric cancer. Results: There were no significant correlations between the 7 factors, including sex, age, smoking history, history of alcohol intake, family history of cancer, tumor type, chemotherapy. The 7 factors of tumor invasion range, pathological type, degree of histological differentiation, metastasized or not, TNM stage, surgical mode and whether used TCM treatment are independent prognostic factors in patients with gastric cancer (P〈0.05). Among them, tumor invasion range, pathological type, degree of histological differ- entiation, metastasized, TNM stage are risk factors for prognosis of gastric cancer, and received radical surgery and TCM treatment are the protective factor for the prognosis of gastric cancer. Conclusion: The patients with a wide range of local invasion of the tumor, complex tumor histological type, poor degree of histological differenti- ation, metastasis, late clinical stage have a poorer prognosis. Accepted radical surgery and TCM treatment can improve the prognosis of gastric cancer.
作者 罗雲 岳小强 李琛瑛 LUO Yun;YUE Xiao-qiang;LI Chen-ying(l.Changhai Hospital of Traditional Chinese Medicine,Second Military Medical University,Shanghai 200433,Chin;Department of Traditional Chinese Medicine,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China;Shanghai TCM-integraed Hospital,Shanghai University of TCM,Shanghai 200082,China)
出处 《中医药导报》 2018年第15期27-32,39,共7页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 上海市中医药事业发展三年行动计划(ZY3-CCCX-3-3038)
关键词 胃癌 单因素分析 COX回归分析 预后因素 gastric cancer single factor analysis COX's proportional hazards regression model prognostic factors
  • 相关文献

参考文献8

二级参考文献62

  • 1杨维良,张新晨,张东伟,马玉林,张浩民,赵志,张建国,梁春林.35岁以下胃癌患者380例临床分析[J].中华胃肠外科杂志,2004,7(5):357-359. 被引量:13
  • 2钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 3Tumur Tsendsuren,Sun-Ming Jun,Xu-Hui Mian.Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer[J].World Journal of Gastroenterology,2006,12(1):43-47. 被引量:88
  • 4Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002.
  • 5Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016.
  • 6Bugat R.Irinotecan in the treatment of gastric cancer[J].Ann Oncol,2003,14(Suppl 2):37 -40.
  • 7Bouche O,Raoul JL,Bonnetain F,et al.Randomized multicenter phase Ⅱ trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2),LV5FU2 plus cisplatin,or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer:a Federation Francophone de Cancerologie Digestive Group Study-FFCD 9803[ J].J Clin Oncol,2004,22 (21):4319-4328.
  • 8Fazio N,Zampino G,Nol F,et al.Irinotecan combined with in fusional 5-fluorouracil and folinic acid (folfiri) in patients with metastatic gastric cancer resistant to cisplatin-containing chemo therapy[J].J Clin Onc,Proc Am Soc Clin Oncol,2004,22:Abstract 4146a.
  • 9Peeters M,Van Laethem JL,Baert F,et al.Phase Ⅱ study of irinotecan+ 5FU/FA for patients with previously treated ad vanced gastric cancer[J].J Clin Onc,Proc Am Soc Clin Oncol,2004,22:Abstract 4076a.
  • 10Bamias A,Papamichael D,Syrigos K,et al.Phase Ⅱ study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer[J].J Chemother,2003,15(3):275 -281.

共引文献603

同被引文献37

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部